Warts
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Pulse BiosciencesCA - Hayward
2 programsCellFX DeviceN/A1 trial
CellFX System DeviceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Pulse BiosciencesCellFX System Device
Pulse BiosciencesCellFX Device
Clinical Trials (2)
Total enrollment: 212 patients across 2 trials
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
Start: Feb 2021Est. completion: Sep 2022150 patients
N/ACompleted
CellFX System for the Treatment of Cutaneous Non-Genital Warts
Start: Jul 2019Est. completion: Dec 202062 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space